129,800 Smith & Nephew SNATS, Inc. $SNN Shares Sold by Teachers Retirement System of The State of Kentucky

Teachers Retirement System of The State of Kentucky reduced its stake in shares of Smith & Nephew SNATS, Inc. (NYSE:SNN – Free Report) by 16.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 683,700 shares of the medical equipment provider’s stock after selling 129,800 shares during the period. Teachers Retirement System of The State of Kentucky owned 0.16% of Smith & Nephew SNATS worth $18,433,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of SNN. Bessemer Group Inc. increased its position in Smith & Nephew SNATS by 23.2% during the third quarter. Bessemer Group Inc. now owns 4,893 shares of the medical equipment provider’s stock worth $132,000 after purchasing an additional 922 shares during the last quarter. Russell Investments Group Ltd. raised its stake in Smith & Nephew SNATS by 62.7% during the third quarter. Russell Investments Group Ltd. now owns 237,366 shares of the medical equipment provider’s stock worth $6,399,000 after purchasing an additional 91,489 shares during the period. Ritholtz Wealth Management boosted its holdings in shares of Smith & Nephew SNATS by 11.4% in the 3rd quarter. Ritholtz Wealth Management now owns 12,094 shares of the medical equipment provider’s stock valued at $326,000 after purchasing an additional 1,241 shares during the last quarter. Ethic Inc. boosted its holdings in shares of Smith & Nephew SNATS by 10.5% in the 3rd quarter. Ethic Inc. now owns 29,168 shares of the medical equipment provider’s stock valued at $786,000 after purchasing an additional 2,762 shares during the last quarter. Finally, Alps Advisors Inc. boosted its holdings in shares of Smith & Nephew SNATS by 4.3% in the 3rd quarter. Alps Advisors Inc. now owns 25,790 shares of the medical equipment provider’s stock valued at $695,000 after purchasing an additional 1,054 shares during the last quarter. 25.64% of the stock is currently owned by hedge funds and other institutional investors.

Smith & Nephew SNATS Trading Down 1.6%

SNN opened at $30.48 on Wednesday. Smith & Nephew SNATS, Inc. has a 1 year low of $26.12 and a 1 year high of $37.09. The firm has a 50 day moving average price of $28.82 and a 200 day moving average price of $30.96. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.14 and a quick ratio of 1.11.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on SNN shares. Zacks Research cut shares of Smith & Nephew SNATS from a “hold” rating to a “strong sell” rating in a research note on Thursday, November 5th. Morgan Stanley lowered Smith & Nephew SNATS from an “overweight” rating to an “equal weight” rating in a research report on Wednesday, September 2nd. Berenberg Bank set a $33.88 target price on Smith & Nephew SNATS in a research report on Friday, September 11th. JPMorgan Chase & Co. cut Smith & Nephew SNATS from an “overweight” rating to a “neutral” rating in a report on Thursday, August 6th. Finally, Wall Street Zen raised Smith & Nephew SNATS from a “hold” rating to a “buy” rating in a research report on Sunday. One investment analyst has rated the stock with a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Reduce” and an average target price of $31.91.

Read Our Latest Report on Smith & Nephew SNATS

About Smith & Nephew SNATS

(Free Report)

Smith & Nephew plc is a global medical technology company that develops and sells products used in surgery, orthopaedics and wound care. Its offerings include implants for hip and knee replacement, instruments and devices for sports medicine and ear, nose and throat procedures, and products designed to manage wounds and support tissue repair. Founded in 1856 in Hull, England, the company began as a pharmacy business before expanding into medical products. It now serves healthcare providers and patients in markets around the world.

Further Reading

Want to see what other hedge funds are holding SNN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Smith & Nephew SNATS, Inc. (NYSE:SNN – Free Report).

Institutional Ownership by Quarter for Smith & Nephew SNATS (NYSE:SNN)

Receive News & Ratings for Smith & Nephew SNATS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew SNATS and related companies with MarketBeat.com's FREE daily email newsletter.